Additionally, the level of the demethylase FTO in the hippocampus of AD mice was lower than that of control mice (P < 0.05), while no significant differences were observed in its expression in the cortex and the cerebellum (Figure 6). This evidence concerns the gene MBD2 and Alzheimer disease.